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Waiting time prioritisation - Evidence from England 1 
Abstract 2 
A number of OECD countries have introduced waiting time prioritisation policies which give 3 
explicit priority to severely ill patients with high marginal disutility of waiting. There is 4 
however little empirical evidence on how patients are actually prioritised. We exploit a 5 
unique opportunity to investigate this issue using a large national dataset with accurate 6 
measures of severity on nearly 400,000 patients. We link data from a national patient-7 
reported outcome measures survey to administrative data on all patients waiting for a 8 
publicly funded hip and knee replacement in England during the years 2009-14. We find that 9 
patients suffering the most severe pain and immobility have shorter waits than those 10 
suffering the least, by about 24% for hip replacement and 11% for knee replacement, and 11 
that the association is approximately linear. These differentials are more closely associated 12 
with pain than immobility, and are larger in hospitals with longer average waiting times. 13 
These result suggests that doctors prioritise patients according to severity even when no 14 
formal prioritisation policy is in place and average waiting times are short.  15 
 16 
Keywords: England; waiting times; severity; prioritisation; patient-reported outcome 17 
measures.  18 
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1 Introduction 19 
Waiting times are a major health policy concern in several OECD countries (Siciliani, 20 
Borowitz, & Moran, 2013). Patients seeking publicly funded care have to wait weeks or 21 
months for common elective (i.e. non-emergency) procedures such as cataract surgery and 22 
hip replacement. For example, in 2012 average waiting times for hip replacement were 23 
above 80 days in several OECD countries (Siciliani, Moran, & Borowitz, 2014). Waiting times 24 
may generate discontent amongst patients as benefits from treatment get postponed and 25 
suffering and uncertainty are prolonged (Lindsay & Feigenbaum, 1984). 26 
In the presence of constraints on capacity combined with public health insurance and 27 
limited co-payments, demand for treatment is likely to exceed supply, so that not all 28 
patients can be treated immediately. Patients are therefore added to a waiting list and wait 29 
for public treatment unless they are willing to pay for private care. Waiting times can be 30 
thought of as a non-monetary price which brings together the demand for and the supply of 31 
treatments in a public healthcare system (Iversen & Siciliani, 2011; Martin & Smith, 1999, 32 
2003).  33 
Several countries have experimented with policies to reduce waiting times, either by 34 
increasing capacity, e.g. by allowing privately-operated providers to treat publicly-funded 35 
patients (Naylor & Gregory, 2009), incentivising providers through maximum waiting time 36 
targets or guarantees (Propper, Sutton, Whitnall, & Windmeijer, 2008), or by limiting 37 
demand through more stringent admission policies. These policies have shown varying 38 
degree of success (Siciliani et al., 2013; Siciliani & Hurst, 2005).  39 
Waiting time prioritisation policies are intended to improve the management of the waiting 40 
list - rather than affect demand or supply - and are common across OECD countries (Siciliani 41 
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et al., 2013). The key idea is simple. Given that waiting lists are unavoidable, they should be 42 
prioritised efficiently to reduce suffering among more severely ill patients with higher 43 
marginal disutility of waiting. From a theoretical perspective, it has been shown that such 44 
policies are welfare improving even in settings where severity is only partially observable, 45 
since prioritisation reduces the overall deadweight loss from waiting (Gravelle & Siciliani, 46 
2008, 2009; see also Siciliani & Iversen, 2012 for a simpler model).  47 
Countries differ in the way prioritisation operates. Some countries have developed formal 48 
prioritisation tools based on detailed scores following a specialist visit (e.g. in Canada and 49 
New Zealand for selected procedures) while others rely on relatively informal and generic 50 
tools (e.g. Australia and Italy, which recommend different maximum waiting times based on 51 
three or four groups of patients). As part of the Western Canada Waiting List project, 52 
scoring tools have been developed that integrate objective and subjective clinical and social 53 
measures to calculate an overall priority score. For hip and knee replacement surgery this 54 
priority score is determined based on patients’ pain on motion (e.g. bending, up to 13 55 
points), pain at rest (e.g. sitting, up to 11 points), ability to walk without pain (up to 7 56 
points), other functional limitations (e.g. putting shoes on, managing stairs, up to 19 points), 57 
among other factors. Similar tools are used in New Zealand to prioritise patients for several 58 
procedures (e.g. for coronary bypass, hip and knee joint replacements) and specialties (e.g. 59 
in general and vascular surgery, orthopaedics, ophthalmology and plastic surgery). In 60 
Norway, a recent policy has introduced a maximum waiting time guarantee where patients 61 
are eligible to treatment within an individually determined waiting time. National guidelines 62 
were developed to stipulate maximum medically acceptable waits for a range of diagnoses 63 
(see Siciliani et al. (2013) for a review of prioritization policies).  64 
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The English NHS does not implement a formal prioritisation policy. Hospital trusts and 65 
consultants are allowed to manage the waiting list as they see fit, which gives rise to local 66 
variation in admission policies. In some instances waiting lists may be managed according to 67 
a first-come-first-serve rule, whereas in others management may take into account severity. 68 
For example, Leeds Teaching Hospitals NHS Trust sets out the requirement to treat patients 69 
‘in order by clinical priority, and then in strict chronological order’ (Leeds Teaching Hospitals 70 
NHS Trust, 2014, p. 4). All hospitals are, however, subject to maximum waiting time targets, 71 
currently set at 18 weeks from referral to treatment (Department of Health, 2015). 72 
Hospitals are routinely assessed with regard to their performance and may have up to 5% of 73 
their revenues withheld when targets are not met. While prioritisation may be considered 74 
to be more important when waits are long, hospitals at risk of breaching the target may 75 
focus on the time individual patients have waited already. Hence, the degree to which 76 
prioritisation policies are implemented locally may differ by average waiting time, although 77 
it is a priori unclear in which direction. 78 
Despite the substantial interest in waiting-time prioritisation by policymakers and 79 
healthcare managers, there is very limited empirical evidence about the degree of waiting 80 
time prioritisation for patients affected by a common condition. It is therefore not evident 81 
a) to what extent patients are prioritised on the waiting list, b) how steep the severity 82 
gradient in waiting is, c) whether waits reduce linearly or non-linearly with severity, and d) 83 
whether prioritisation differs between hospitals with short and long average waiting time. 84 
Without this information it is difficult for decision-makers to determine whether further 85 
prioritisation should be encouraged. We fill this gap in knowledge.  86 
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The lack of empirical studies may be explained by the absence of accurate measures of 87 
severity in large-scale administrative databases. These are typically limited to measures of 88 
comorbidity burden, which are poor proxies for general health status (Gutacker, Siciliani, 89 
Moscelli, & Gravelle, 2015). We take advantage of a new dataset containing detailed 90 
measures of patient self-reported health status collected alongside routine surgery as part 91 
of the national patient-reported outcome measures (PROM) programme. Since April 2009, 92 
all patients undergoing four elective surgical procedures (unilateral hip replacement, 93 
unilateral knee replacement, groin hernia repair and varicose vein surgery) in the English 94 
National Health Service (NHS) have been invited to report their health status before and 95 
several months after surgery (Department of Health, 2008). The pre-operative health status 96 
of the patient is measured through condition-specific instruments (such as the Oxford Hip 97 
Score) and the generic EuroQol-5D instrument. 98 
We focus on hip and knee replacement, which are common elective procedures and are the 99 
focus of waiting time prioritisation policies in a number of OECD countries (e.g. Canada, 100 
New Zealand). We contribute to the literature in two ways: First, we test the extent to 101 
which more severely ill patients (as measured by the Oxford Hip and Knee Scores (OHS/OKS) 102 
which capture patients’ joint-related pain and degree of mobility and autonomy) in the 103 
English NHS wait less. To our knowledge, this is the first study to estimate the degree of 104 
waiting time prioritisation using a large, multi-centre dataset of linked administrative and 105 
detailed patient-reported information on severity. As such it provides a policy-relevant 106 
assessment of the current status quo. Second, we explore the differential role of pain and 107 
mobility on waiting time by splitting the Oxford scores into sub-components. The general 108 
public often considers pain to have a more important impact on health-related quality of life 109 
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(HRQoL) than mobility (Devlin, 2016; Dolan, 1997; Szende, Oppe, & Devlin, 2007) but it is 110 
unclear whether these dimensions of health are taken into account differentially by 111 
clinicians when prioritising patients. We estimate Poisson models to allow for the discrete 112 
measure of inpatient waits (in days) and its skewed distribution. Critically, we control for 113 
hospital fixed effects which are allowed to vary across years. Therefore, the effect of 114 
severity on waiting time is identified from patients with different severity within the same 115 
hospital in a given year, and is not confounded by differences in efficiency and production 116 
environment across hospitals and over time.  117 
Our key result is that patients with higher severity tend to wait less but the effect appears 118 
modest. Hip replacement patients in the top severity group wait approximately 9% (7 days) 119 
less than those with average severity, and the total gap between the most and least severe 120 
patient groups is 23% (20 days). There is heterogeneity across treatments: the gradient for 121 
patients in need of knee replacement is substantially flatter, with no discernible 122 
prioritisation taking place between patients in above average severity. Moreover, while 123 
both mobility and pain affect patients’ wait for hip replacement patients, only pain matters 124 
for knee replacement.  125 
When we split the sample between hospitals with high (above median) and low (below 126 
median) waits, we find that the gradient between severity and waiting is more pronounced 127 
in hospitals with longer waits. This suggests that doctors enhance prioritisation when waits 128 
increase to reduce the overall disutility from waiting. Overall we find that prioritisation is 129 
currently limited in scope and therefore we suggest that governments could do more to 130 
further encourage waiting time prioritisation.  131 
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1.1 Related literature 132 
The study contributes to the existing literature on the role of waiting times. A key focus has 133 
been the estimation of demand and supply elasticities to waiting times, typically finding that 134 
demand is inelastic to waiting times (elasticity of about -0.1) while supply elasticity 135 
estimates vary depending on study design (see Iversen & Siciliani, 2011 for a review; Martin, 136 
Rice, Jacobs, & Smith, 2007; Martin & Smith, 1999, 2003). Some studies focus on specific 137 
policies such as the introduction of maximum waiting-time guarantees combined with 138 
penalties for non-compliance (e.g. Dimakou, Parkin, Devlin, & Appleby, 2009; Propper, 139 
Sutton, et al., 2008) or competition (Propper, Burgess, & Gossage, 2008; Siciliani & Martin, 140 
2007). Other studies focus on waiting-time inequalities by socioeconomic status. Cooper, 141 
McGuire, Jones, and Grand (2009) find that people living in more affluent areas waited less 142 
than those in more deprived areas for cataract, hip and knee replacement surgery 143 
performed in the English NHS (see also Laudicella, Siciliani, & Cookson, 2012, who focus on 144 
variations in waiting times within hospitals). Similarly, Monstad, Engesæter, and Espehaug 145 
(2014) find that in Norway richer men and more educated women wait less for hip 146 
replacement (see also Kaarboe & Carlsen, 2014). Similar evidence for Australia is provided 147 
by Sharma, Siciliani, and Harris (2013) and Johar, Jones, Keane, Savage, and Stavrunova 148 
(2013). There are also a number of studies that estimate the effect of longer waiting time on 149 
pre- and post-operative patient health. Hoogeboom et al. (2009) provide a systematic 150 
review of the medical literature and find that longer waiting time is not associated with 151 
deteriorations in health status while waiting up to six months. Using observational data 152 
from the national PROM programme in England, Nikolova, Harrison, and Sutton 153 
(forthcoming) estimate that patients’ post-operative health status deteriorates by 0.1% of 154 
the outcome measure range per additional week of wait. 155 
M
A
N
U
S
C
R
IP
T
 
A
C
C
E
P
T
E
D
ACCEPTED MANUSCRIPT
8 
 
Some recent studies focus on prioritisation. Askildsen, Holmås, and Kaarboe (2011) compare 156 
recommended maximum waiting times by medical guidelines with actual waiting times in 157 
Norway. These guidelines recommend a differential waiting time across different conditions 158 
rather than within a given condition. They find that patients with most severe conditions 159 
receive lower priority than recommended. The related study by Januleviciute, Askildsen, 160 
Kaarboe, Holmås, and Sutton (2013) suggests that the introduction of such guidelines had 161 
no effect on improving waiting time prioritisation across four major severity groups (see also 162 
Askildsen, Holmås, & Kaarboe, 2010). Using data from New South Wales, Johar (2014) 163 
estimates that the introduction of (non-compulsory) waiting time recommendations may 164 
have reduced the priority given to most severe patients, thereby increasing their waiting 165 
time. 166 
2 Methods 167 
2.1 Data 168 
We use patient-level data from Hospital Episode Statistics (HES) for all elective admissions 169 
for patients aged 18 or over who underwent NHS-funded primary (i.e. non-revision) hip or 170 
knee replacement surgery between April 2009 and March 2014 in NHS or private providers 171 
(see Department of Health (2008) for procedure codes). HES contains rich information on 172 
patients’ demographic and medical characteristics, small area of residence and on the 173 
hospital stay itself. Privately-funded patients treated in private hospitals are not included in 174 
HES and are therefore absent from our analysis. We also exclude patients who waited 175 
longer than one year. 176 
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We extract data on a number of patient characteristics from HES, including patients’ age, 177 
gender, the number of emergency admissions in the year prior to their joint replacement 178 
surgery, as well as the number of Elixhauser comorbid conditions recorded in all admissions 179 
in the previous year or the current admission (Elixhauser, Steiner, Harris, & Coffey, 1998; 180 
Gutacker, Bloor, & Cookson, 2015). We measure waiting time for each patient as the time 181 
(in days) between the specialist’s decision to add the patient to the waiting list and their 182 
admission. We use the 2010 Index of Deprivation (McLennan et al., 2011) to attribute to 183 
each patient the proportion of residents claiming means-tested social security benefits in 184 
their Lower Super Output Area (LSOA, average population of 1,500 inhabitants), which we 185 
interpret as a proxy of income deprivation. 186 
We link these data to information obtained as part of the national PROM programme 187 
(Department of Health, 2008). Since April 2009, all NHS-funded hip and knee replacement 188 
patients are invited to report their health status and health related quality of life before and 189 
six months after surgery using a paper-based questionnaire. The pre-operative 190 
questionnaire is administered by the hospital providing the surgery, either on admission or 191 
during the last outpatient appointment preceding admission. The paper questionnaires are 192 
then collated and sent to a central agency to be scanned and linked to the inpatient records 193 
using a linkage algorithm developed by the Health & Social Care Information Centre. The 194 
post-operative questionnaire is posted to patients by the central agency six months after 195 
surgery. Participation in the PROM survey is compulsory for providers but optional for 196 
patients. Complete pre- and post-operative questionnaires can be linked to HES records for 197 
about 60% of patients. We provide characteristics of responders and non-responders in 198 
Table 2 in the results section. 199 
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Each PROM questionnaire includes a condition-specific and a generic instrument. The 200 
Oxford Hip or Knee Scores (OHS/OKS) are condition-specific instruments with 12 questions 201 
on joint-related functioning and pain (Dawson, Fitzpatrick, Carr, & Murray, 1996; Dawson, 202 
Fitzpatrick, Murray, & Carr, 1998). Each item is scored on a five-point scale, ranging from 203 
four (no problems) to zero (severe problems). The overall score ranges from zero (worst) to 204 
48 (best) and is calculated by simple summation across items. For our main analysis we split 205 
this score into eleven groups, composed of twelve equally sized groups of four points each 206 
with the top two groups merged due to low numbers of patients (coded as 0-4, 5-8, 9-12, 207 
13-16, 17-20, 21-24, 25-28, 29-32, 33-36, 37-40, 41-48). This allows for a flexible estimation 208 
of a (potentially) non-linear relationship between severity and waiting times. In further 209 
analysis we also use two sub-scores based on items relating to mobility and pain (see 210 
Appendix for how items are matched to sub-scores); again coded as groups of four points. 211 
The PROM questionnaire also includes the EQ-5D, a generic measure of HRQoL that can be 212 
applied to different health conditions (Brooks, 1996) and can be converted into utility scores 213 
using the UK general population tariff with one indicating full health and zero indicating a 214 
health state equivalent to being dead (Dolan, 1997). We focus on the Oxford scores 215 
throughout this paper because i) we expect them to be more sensitive to differences in 216 
severity as considered by the consultant than the EQ-5D, ii) we do not wish to make 217 
comparisons across conditions, and iii) their focus on pain and mobility mirrors the criteria 218 
used for prioritisation of hip replacement patients in the Canadian context (see 219 
Introduction). The correlation between the condition-specific and generic measures is high, 220 
with rho = 0.74 for OHS and the EQ-5D utility score and rho = 0.71 for OKS and EQ-5D utility 221 
score. We estimate that, on average, a 4 point increase on the pre-operative Oxford scores 222 
is associated with a utility increase of 0.114 (SE=0.0005) for both  hip and knee replacement 223 
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patients, adjusted for case-mix (see Appendix). To put this into context, based on the 224 
current NICE cost-effectiveness thresholds value of around £30,000 per quality-adjusted life 225 
year the NHS in England would be willing to spend up to £3,420 to allow one patient to 226 
spend a year in a 0.114 utility points (=4 OHS points) better health state (NICE, 2008).  227 
No ethical approval was required for secondary data analysis. 228 
2.2 Empirical analysis 229 
We estimate fixed effects Poisson regression models to relate the number of days on the 230 
waiting list  for patient  in hospital  in year  to observed patient characteristics and 231 
the provider of care (Cameron & Trivedi, 1998). The use of Poisson regression is preferable 232 
over (log-transformed) linear regression because it accounts for the skewed distribution of 233 
waiting time and does not suffer from re-transformation bias (Gould, 2011; Manning, 1998). 234 
Our model is specified as  235 
 = exp	(
 + 
 + ℎ) 
Coefficient estimates are semi-elasticities, representing the proportionate change in the 236 
dependent variable resulting from a one unit change in the independent variable. We also 237 
report average partial effects (APEs) on the untransformed scale. We obtained cluster-238 
robust Huber-White standard errors to account for potential over-dispersion (Cameron & 239 
Trivedi, 1998). 240 
The variable  is our key variable of interest. It measures severity in terms of patients’ 241 
pain at rest or in movement, and their ability to move about. This information is available 242 
from a national census of all patients undergoing elective hip or knee replacement (more 243 
details are provided in the data section). The vector  thus provides an estimate of the 244 
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degree of waiting-time prioritisation on the list according to severity as measured by pain 245 
and immobility. We allow for the relationship between severity and waiting time to be non-246 
linear by splitting severity into eleven bands, thus allowing for a potentially non-linear 247 
‘severity gradient’ in waiting time.  248 
There may be a number of other patient characteristics that are used for prioritisation and 249 
are correlated with unobserved components of severity. We explore the robustness of the 250 
estimated severity gradient in  to the inclusion of these characteristics. The vector  251 
includes the patient’s age (coded as 0-44, 45-54, 55-64, 65-74, 75-84 and 85+), sex and age-252 
sex interactions as well as the number of emergency admissions to hospital during the past 253 
365 days, indicators for Elixhauser co-morbid conditions and approximate socio-economic 254 
status (in quintile groups). A priori, age should affect only the eligibility criteria for a hip (or 255 
knee) replacement within the NHS, not whether they are prioritised on the list conditional 256 
on being added to the list. However, age may be correlated with other factors of severity 257 
not already accounted for through patients’ self-reported health. Similarly, patients may be 258 
prioritised according to their co-morbidity burden and general health status as 259 
approximated by past emergency admissions.  260 
All models include hospital-year-specific fixed effects ℎ  to control for differences in waiting 261 
times across hospitals which may arise from (potentially time-varying) unobserved supply 262 
factors (e.g. availability of beds, staffing, infrastructure, management and organization, and 263 
quality) and unobserved regional demand factors such as overall health of the population. 264 
This modelling strategy captures general time trends and differences across hospitals in 265 
each year and over time so that the coefficients of on severity and other control variables 266 
are estimated from within provider-year variation only.  267 
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All analyses were conducted in Stata version 13. 268 
3 Results 269 
3.1 Descriptive statistics 270 
Over the five-year period considered there have been about 297,000 publicly funded hip 271 
replacement procedures and about 325,000 knee replacement procedures in the English 272 
NHS. Pre-operative PROM data are available for approximately 64% of hip replacement 273 
patients and 62% of knee replacement patients. Descriptive statistics for these patients are 274 
provided in Table 1.  275 
For hip replacement patients, the average observed waiting time (our dependent variable) is 276 
82 days. Patients are on average 68 years old and nearly 60% of patients are female. The 277 
average pre-operative OHS is 17.5 points (on a range from 0 to 48). Patients had an average 278 
of 0.1 emergency admissions in the year proceeding hospital admission for an elective hip 279 
replacement. Only 66% of patients had at least one comorbid condition with only 7% 280 
reporting five or more. Approximately 17% of patients are treated in privately-operated 281 
hospitals. The average waiting time for knee replacement surgery is slightly higher than for 282 
hip replacement surgery (86 vs 82 days). The other patient characteristics are comparable to 283 
those of hip replacement patients and are not repeated here (but see Table 1 for details). 284 
The distributions of pre-operative OHS and OKS are shown in Figure 1 and Figure 2. 285 
[Table 1 here] 286 
[Figure 1 and Figure 2 here] 287 
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Not all patients respond to the PROM survey. Table 2 compares the characteristics of 288 
responders and non-responders as derived from HES. The gap in average waiting time 289 
between responders and non-responders is two days for hip replacement patients and three 290 
days for knee replacement patients. Given that the average waiting time is above 80 days, 291 
these differences are negligible. Similarly, while non-responders tend to be slightly older, 292 
have a higher comorbidity burden and have been admitted more often to hospital as an 293 
emergency in the preceding year, these differences are small in clinical and economic terms 294 
and unlikely to induce bias.  295 
[Table 2 here] 296 
There are substantial differences in waiting time across hospitals. For example, hip 297 
replacement patients attending one of the 131 private hospitals wait on average 46.2 days 298 
compared with 89.8 days in one of the 153 public NHS hospitals (all based on responders 299 
and non-responders). This illustrates the need to control for hospital fixed effects in 300 
estimating the severity gradient in waiting times.  301 
3.2 Estimates of the severity gradient in waiting time 302 
Table 3 and Table 4 provide our key results for patients in need of hip and knee 303 
replacement, respectively. All specifications include hospital-year fixed effects (not 304 
reported). Differences in waiting times across patients with different severity are therefore 305 
unlikely to be confounded by differences in local supply or demand factors. The model in 306 
Column (1) only includes the Oxford Score. The model in Column (2) extends this to account 307 
for patient’s age and gender, and the model in Column (3) contains a full set of control 308 
variables. The severity gradient is formed by the coefficients on each of the Oxford Score 309 
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groups. It is robust to the inclusion of additional control variables. We therefore focus our 310 
discussion on the results in Column (3).  311 
Table 3 suggests that hip replacement patients with lower severity, as measured by the 312 
Oxford Hip Score, wait longer. The quantitative effect appears to be modest. Compared to 313 
patients in the top severity group (0-4 points) patients of average severity (17-20 points) 314 
wait 9% (or about 7 days) longer. Patients with least severity (with a score above 41 points) 315 
wait approximately 24% (20 days) longer. Figure 3 plots the average partial effect of Oxford 316 
Hip Scores on waiting times in terms of days waited. The severity gradient increases linearly 317 
across the entire range, suggesting a simple prioritisation mechanism. 318 
[Table 3 here] 319 
[Figure 3 here] 320 
Several other patient characteristics are also predictive of waiting time. For a given level of 321 
severity, older patients tend to wait less. Patients aged 65 years or older wait about 14-17% 322 
less than patients below 45 years (and about 8-11% less than patients aged 45-54). Male 323 
patients wait 7% less. The age gradient is not statistically significantly different for men and 324 
women and it is therefore not reported. Patients who had been admitted to hospital as an 325 
emergency within the last year wait less than those who had not. Only few Elixhauser 326 
comorbidities have a statistically significant effect on observed waiting time (not reported). 327 
Finally, there remains a statistically significant but very small socio-economic gradient in 328 
waiting time even after conditioning on pre-operative severity and other patient 329 
characteristics. Patients in the most income-deprived fifth of neighbourhoods wait 330 
approximately 1% longer than those in the least deprived fifth of neighbourhoods. If some 331 
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of these patient characteristics pick up unobserved severity differences, our severity 332 
gradient should be considered a lower bound estimate of the true gradient. 333 
Table 4 reports results for knee replacement. The results are analogous to those for hip 334 
replacement, though the gradient associated with OKS is notably flatter at about half the 335 
slope. Patients below 21 OKS points do not differ significantly in waiting times. Patients with 336 
scores in the range of 21 to 48 wait about 3-11% longer compared to patients with a score 337 
below 21. The overall effect of severity on waiting time is small and different severity groups 338 
differ by no more than 10 days (see Figure 3). Again, prioritisation appears to be almost 339 
linear. Patients 65 years or older wait about 7-10% less than younger patients. There is no 340 
statistically significant difference across genders or socio-economic groups. 341 
[Table 4 here] 342 
3.3 Different dimensions of severity: pain or mobility 343 
We now explore whether prioritisation differs by pain and mobility. The results in Table 5 344 
show that, for hip replacement surgery, both pain and mobility matter but the effect of pain 345 
on prioritisation is larger. For example, a patient who scores 13-16 points on the pain score 346 
(higher scores indicate lower pain) is expected to wait 8% (7 days) longer than a patient of 347 
extreme pain, for a given level of mobility (see also Figure 4). Conversely, a patient who 348 
scores 13-16 points on the mobility score is only expected to wait 4% (3 days) longer than 349 
the most immobile patient. 350 
The results are different for knee replacement. Here, it is mainly different degrees of pain 351 
that generate differences in waiting times and account for most of the gradient. Variations 352 
in severity due to mobility have generally no effect on prioritisation (Figure 4).  353 
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[Table 5 here] 354 
[Figure 4 here] 355 
3.4 Hospitals with long and short waiting times  356 
We also test whether prioritisation is more pronounced when waiting times are longer. To 357 
do so we split the sample into two groups, hospitals with an average wait above the median 358 
and hospitals below the median. The median hospital level waiting time is calculated on all 359 
patients undergoing elective hip or knee replacement surgery, i.e. including those that did 360 
not participate in the PROM survey, and is 77 days for hip replacement surgery and 81 days 361 
for knee replacement surgery. 362 
Table 6 provides the results. We focus on our preferred specification, which includes all 363 
controls. It shows that the prioritisation gradient is comparable among the two groups when 364 
differences in waits are measured in percentage points (with possibly a stronger gradient in 365 
long-wait hospitals for low OHS scores, i.e. high severity, and a weaker gradient for high 366 
scores). However, the underlying levels are different.  367 
Figure 5 plots the gradients in days. The least severe patients (OHS score 41-48) wait up to 368 
23 days longer than severe patients in high-wait hospitals. Conversely, similar patients in 369 
low-wait hospitals wait only up to 14 days longer. Therefore waiting time prioritisation is 370 
more pronounced in absolute terms in hospitals with longer average waiting times. 371 
A similar picture arises when looking at knee replacement patients (Figure 6). Prioritisation 372 
is more pronounced in long-wait hospitals. In short-wait hospitals there are very little 373 
discernible differences between different severity groups. In high-wait hospitals, 374 
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prioritisation tends to be linear and patients with lower severity wait up to about 12 days 375 
longer. 376 
 [Table 6 here]  377 
[Figure 5 and Figure 6 here] 378 
4 Discussion 379 
Many OECD countries are either faced with cuts to their healthcare budgets or small 380 
nominal growth, in part driven by efforts to reduce budget deficits in the aftermath of the 381 
global economic crisis. This is likely to affect the supply of care, which can no longer keep up 382 
with the increasing demand for care due to e.g. increased expectations, cost-increasing 383 
medical innovation and people living longer with multiple chronic conditions. As a result, 384 
many healthcare systems are seeing and will see increases in waiting time for elective 385 
surgery. 386 
Waiting time prioritisation policies are one way to optimise the management of the waiting 387 
list and thus maximise patients’ welfare. A number of countries have adopted formal or 388 
informal processes by which patients are prioritised according to their observed severity, i.e. 389 
the need for timely care. Yet, there is little empirical evidence on the degree to which 390 
prioritisation policies are implemented or how steep the severity gradient in waiting time is 391 
in practice. 392 
Using data on waiting time and self-reported pre-operative health status for over 200,000 393 
patients undergoing elective hip and knee replacement in the English NHS, we demonstrate 394 
a statistically significant, albeit modest severity gradient in waiting time. For every four 395 
points on the Oxford Hip Score (ranging from 0 (worst) to 48 (best)) we see an increase in 396 
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waiting time of approximately two days. This applies across the entire range of severity. 397 
Conversely, waiting times increase by approximately 1-2 days for every four points increase 398 
on the Oxford Knee Score for knee replacement patients with pre-operative scores above 399 
20. There is no discernible gradient among more severe patients. Prioritisation for hip and 400 
knee replacement surgery is driven primarily by the amount of pain patients receive from 401 
their joint, with less importance given to mobility.  402 
The overall severity gradient in waiting time seems modest in absolute terms but is not 403 
negligible relative to the average waiting time: The gap between the most and least severe 404 
groups of patients is approximately 25% (=20/82 days) of the average waiting time for hip 405 
replacement patients, and 12% (=10/87 days) for knee replacement patients. One reason 406 
why we do not observe more prioritisation may be because the English NHS has not 407 
adopted a formal model of prioritisation for hip and knee replacement surgery, i.e. it largely 408 
implements a ‘first-come-first-serve’ model, or because average waiting times are now at a 409 
historic low so that prioritisation is considered less important.  410 
Prioritisation is enhanced when waits are longer. This is supported by our finding that 411 
hospitals with above median waiting times tend to show stronger prioritisation in absolute 412 
terms than hospitals with below median waiting times. It also suggests that hospitals more 413 
at risk of breaching maximum waiting time targets are not necessarily less inclined to take 414 
severity into account when managing their waiting list. Indeed, one might argue that the 415 
benefits of prioritisation are larger when waiting times are longer, so that hospitals with 416 
above median waiting time should indeed engage more intensively in prioritising waiting 417 
lists by severity as we observe in our data. If so, as waiting times begin to gradually increase 418 
again in the English NHS, we would expect to see more prioritisation taking place. 419 
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Several other patient characteristics are associated with differences in waiting time. For 420 
example we observe an age gradient. This may be considered as pro-elderly evidence of 421 
inequality in access to care. However, it may also be a selection issue in terms of which 422 
patients are able and willing to choose privately funded treatment – for example, if elderly 423 
patients are wealthier than younger patients with severe osteoarthritis. We also cannot rule 424 
out that our measure of severity is imperfect and that these variables capture some 425 
unobserved component of severity. In this case, our estimate of the severity gradient is a 426 
lower bound. 427 
More generally, our study has a number of possible limitations. First, our pre-operative 428 
health status measures are taken at the time of admission, not when the specialist makes 429 
the decision to add the patient to the waiting list. This may potentially overestimate the 430 
severity of some patients if the patients’ health status deteriorates during long waits. 431 
However, a recent systematic review by Hoogeboom et al. (2009) finds that the degree of 432 
deterioration in health during waiting times <6 months is likely to be minimal and we 433 
therefore do not expect this to be a serious concern for our study. Second, not all patients 434 
respond to the PROM questionnaire, which may give rise to possible selection bias. We did 435 
not pursue to model sample selection explicitly due to a lack of valid exclusion restrictions. 436 
However, any sample selection bias is likely to be small as we find only very small difference 437 
in the average waiting time for responders and non-responders.  438 
5 Conclusions 439 
Hip and knee replacement patients in the English NHS are being prioritised according to 440 
severity, even though no formal national prioritisation policy is currently in place. However, 441 
the degree of prioritisation may be considered modest, especially for knee replacement 442 
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surgery with a gap of only 10 days (12% of the mean waiting time) between patients with 443 
the most and least severe problems of pain and immobility. The modest slope of the 444 
severity gradient in waiting time suggests that those responsible for the waiting list either 445 
believe that the marginal disutility of waiting for surgery does not vary substantially across 446 
patients, or that they find it difficult (perhaps even unethical) to prioritise patients according 447 
to their pain and limitations to mobility. There is a clear rationale for prioritising patients on 448 
the list: the overall pain and limitations to mobility can be reduced by letting more severely 449 
incapacitated patients wait less. This is important even if waiting has no negative impact on 450 
patients’ long-term prognosis. Policy makers in the English NHS may wish to follow the 451 
example of other OECD countries and consider implementing formal policies to encouraging 452 
further prioritisation on the list if the current level of informal prioritisation is considered 453 
insufficient.  454 
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7 Tables and Figures 
Table 1: Descriptive Statistics 
  
Hip replacement 
(N=190,103)   
Knee replacement 
(N=203,080) 
Description Mean SD   Mean SD 
Waiting time (in days) 81.7 50.5 
 
86.3 53.6 
Pre-operative Oxford Score 17.5 8.2 
 
18.3 7.8 
Age 67.7 11.3 
 
69.1 9.3 
Gender (0=female, 1=male) 0.41 0.5 
 
0.43 0.5 
Proportion of local population receiving unemployment benefits 0.12 0.1 
 
0.13 0.1 
Number of emergency admissions in last 365 days 0.11 0.4 
 
0.10 0.5 
Number of Elixhauser comorbidities: 0 0.34 0.5 
 
0.26 0.4 
Number of Elixhauser comorbidities: 1 0.28 0.5 
 
0.28 0.4 
Number of Elixhauser comorbidities: 2 0.19 0.4 
 
0.22 0.4 
Number of Elixhauser comorbidities: 3-4 0.13 0.3 
 
0.16 0.4 
Number of Elixhauser comorbidities: 5+ 0.07 0.2 
 
0.08 0.3 
Financial year 2009/10 0.15 0.4 
 
0.16 0.4 
Financial year 2010/11 0.19 0.4 
 
0.19 0.4 
Financial year 2011/12 0.21 0.4 
 
0.21 0.4 
Financial year 2012/13 0.22 0.4 
 
0.22 0.4 
Financial year 2013/14 0.23 0.4   0.23 0.4 
Treated in private (non-NHS) hospital (0=no, 1=yes) 0.17 0.4  0.16 0.4 
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Table 2: Comparison of responders and non-responders 
 
Hip replacement   Knee replacement 
 
Responders 
(N=190,106) 
 
Non-responders 
(N=107,065) 
 
Responders 
(N=203,084) 
 
Non-responders 
(N=122,285) 
Variable Mean SD   Mean SD   Mean SD   Mean SD 
Waiting time 81.7 50.5 
 
83.7 57.3 
 
86.3 53.6 
 
89.1 60.3 
Age 67.7 11.3 
 
68.7 11.7 
 
69.1 9.3 
 
70.0 9.5 
Gender (0=female, 1=male) 0.41 0.5 
 
0.40 0.5 
 
0.43 0.5 
 
0.42 0.5 
Proportion of local population receiving 
social security benefits 0.12 0.1 
 
0.13 0.1 
 
0.13 0.1 
 
0.14 0.1 
Number of Elixhauser comorbidities 1.59 2.7 
 
1.78 3.7 
 
1.84 2.9 
 
1.96 3.4 
Number of emergency admissions in last 365 
days 0.11 0.4 
 
0.15 0.5 
 
0.10 0.5 
 
0.13 0.5 
Treated in private (non-NHS) hospital (0=no, 
1=yes) 0.17 0.4   0.17 0.4   0.16 0.4   0.17 0.4 
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Table 3: Regression results - hip replacement 
  
Pre-operative health 
only 
  
Pre-operative health 
and age/sex 
  Full adjustment 
Covariate Est SE     Est SE     Est SE   
Pre-operative score: 5-8 0.039 0.008 *** 
 
0.036 0.008 *** 
 
0.037 0.008 *** 
Pre-operative score: 9-12 0.056 0.007 *** 
 
0.054 0.007 *** 
 
0.055 0.008 *** 
Pre-operative score: 13-16 0.077 0.007 *** 
 
0.074 0.007 *** 
 
0.077 0.007 *** 
Pre-operative score: 17-20 0.092 0.007 *** 
 
0.090 0.007 *** 
 
0.094 0.007 *** 
Pre-operative score: 21-24 0.109 0.008 *** 
 
0.107 0.008 *** 
 
0.112 0.008 *** 
Pre-operative score: 25-28 0.132 0.008 *** 
 
0.132 0.008 *** 
 
0.137 0.008 *** 
Pre-operative score: 29-32 0.153 0.008 *** 
 
0.154 0.008 *** 
 
0.160 0.009 *** 
Pre-operative score: 33-36 0.162 0.010 *** 
 
0.162 0.010 *** 
 
0.168 0.010 *** 
Pre-operative score: 37-40 0.193 0.013 *** 
 
0.196 0.013 *** 
 
0.204 0.013 *** 
Pre-operative score: 41-48 0.229 0.022 *** 
 
0.231 0.022 *** 
 
0.239 0.022 *** 
Age: 45-54 
    
-0.060 0.011 *** 
 
-0.063 0.011 *** 
Age: 55-64 
    
-0.096 0.010 *** 
 
-0.100 0.010 *** 
Age: 65-74 
    
-0.135 0.010 *** 
 
-0.141 0.010 *** 
Age: 75-84 
    
-0.156 0.010 *** 
 
-0.163 0.010 *** 
Age: 85+ 
    
-0.161 0.012 *** 
 
-0.167 0.012 *** 
Male 
    
-0.067 0.013 *** 
 
-0.067 0.013 *** 
Number of emergency admissions in last 365 days
        
-0.019 0.004 *** 
SES (2nd quintile) 
        
0.005 0.004 
 SES (3rd quintile) 
        
0.005 0.004 
 SES (4th quintile) 
        
0.014 0.004 *** 
SES (5th quintile - most deprived)                 0.011 0.004 ** 
Pseudo R2 0.244       0.247       0.248     
N 190,103       190,103       190,103     
Notes: *** p<0.001, ** p<0.01, * p<0.05. Estimates are semi-elasticities and relative to patient aged <44, female, and pre-operative Oxford score of 0-4. All models include 
hospital-year fixed effects. Standard errors are robust to over-dispersion. Age-sex interactions, Elixhauser comorbidities and year effects not reported. 
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Table 4: Regression results - knee replacement 
  
Pre-operative health 
only 
  
Pre-operative health 
and age/sex 
  Full adjustment 
Covariate Est SE     Est SE     Est SE   
Pre-operative score: 5-8 -0.011 0.009 
  
-0.012 0.009 
  
-0.012 0.009 
 Pre-operative score: 9-12 0.002 0.009 
  
0.003 0.009 
  
0.005 0.009 
 Pre-operative score: 13-16 0.005 0.009 
  
0.009 0.009 
  
0.011 0.009 
 Pre-operative score: 17-20 0.004 0.009 
  
0.010 0.009 
  
0.013 0.009 
 Pre-operative score: 21-24 0.016 0.009 
  
0.024 0.009 ** 
 
0.028 0.009 ** 
Pre-operative score: 25-28 0.028 0.009 ** 
 
0.038 0.009 *** 
 
0.042 0.009 *** 
Pre-operative score: 29-32 0.054 0.010 *** 
 
0.066 0.010 *** 
 
0.070 0.010 *** 
Pre-operative score: 33-36 0.058 0.011 *** 
 
0.072 0.011 *** 
 
0.077 0.011 *** 
Pre-operative score: 37-40 0.075 0.015 *** 
 
0.090 0.015 *** 
 
0.095 0.015 *** 
Pre-operative score: 41-48 0.092 0.025 *** 
 
0.107 0.025 *** 
 
0.111 0.025 *** 
Age: 45-54 
    
-0.006 0.020 
  
-0.008 0.020 
 Age: 55-64 
    
-0.027 0.019 
  
-0.030 0.019 
 Age: 65-74 
    
-0.068 0.019 *** 
 
-0.072 0.019 *** 
Age: 75-84 
    
-0.086 0.019 *** 
 
-0.090 0.019 *** 
Age: 85+ 
    
-0.093 0.020 *** 
 
-0.095 0.020 *** 
Male 
    
-0.012 0.029 
  
-0.010 0.029 
 Number of emergency admissions in last 365 days 
        
-0.011 0.003 *** 
SES (2nd quintile) 
        
0.003 0.004 
 SES (3rd quintile) 
        
-0.004 0.004 
 SES (4th quintile) 
        
-0.005 0.004 
 SES (5th quintile - most deprived)                 -0.002 0.004   
Pseudo R2 0.230 
   
0.232 
   
0.232 
  N 203,080       203,080       203,080     
Notes: *** p<0.001, ** p<0.01, * p<0.05. Estimates are semi-elasticities and relative to patient aged <44, female, and pre-operative Oxford score of 0-4. All models include 
hospital-year fixed effects. Standard errors are robust to over-dispersion. Age-sex interactions, Elixhauser comorbidities and year effects not reported. 
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Table 5: Effect of pain and mobility on waiting time 
  Hip replacement   Knee replacement 
 
Pain 
 
Functioning 
 
Pain 
 
Functioning 
Covariate Est SE     Est SE   
 
Est SE     Est SE   
Pre-operative score: 5-8 0.029 0.004 *** 
 
0.013 0.005 ** 
 
0.022 0.003 *** 
 
0.001 0.005 
 Pre-operative score: 9-12 0.053 0.004 *** 
 
0.031 0.005 *** 
 
0.044 0.004 *** 
 
-0.007 0.006 
 Pre-operative score: 13-16 0.081 0.006 *** 
 
0.042 0.006 *** 
 
0.065 0.007 *** 
 
0.000 0.006 
 Pre-operative score: 17-20 0.099 0.009 *** 
 
0.056 0.007 *** 
 
0.084 0.020 *** 
 
0.012 0.007 
 Pre-operative score: 21-24 0.103 0.021 *** 
 
0.096 0.013 *** 
     
0.031 0.009 *** 
Pre-operative score: 25-28 
            
0.015 0.019 
 Pseudo R2 0.248               0.232             
N 190,103               203,080             
Notes: *** p<0.001, ** p<0.01, * p<0.05. Estimates are semi-elasticities and relative to pre-operative score of 0-4. All models include hospital-year fixed effects plus a full set 
of control variables (see text). Standard errors are robust to over-dispersion. 
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Table 6: Difference in waiting time gradient between short and long wait hospitals 
  Hip replacement   Knee replacement 
 
Low waiting time 
hospitals  
High waiting time 
hospitals  
Low waiting time 
hospitals  
High waiting time 
hospitals 
Covariate Est SE     Est SE   
 
Est SE     Est SE   
Pre-operative score: 5-8 0.001 0.017 
  
0.044 0.009 *** 
 
-0.028 0.023 
  
-0.008 0.010 
 Pre-operative score: 9-12 0.027 0.016 
  
0.060 0.008 *** 
 
-0.014 0.022 
  
0.009 0.010 
 Pre-operative score: 13-16 0.038 0.016 * 
 
0.086 0.008 *** 
 
-0.010 0.022 
  
0.016 0.010 
 Pre-operative score: 17-20 0.056 0.016 *** 
 
0.103 0.008 *** 
 
0.008 0.022 
  
0.014 0.010 
 Pre-operative score: 21-24 0.085 0.017 *** 
 
0.117 0.009 *** 
 
0.016 0.022 
  
0.030 0.010 ** 
Pre-operative score: 25-28 0.117 0.017 *** 
 
0.140 0.009 *** 
 
0.046 0.023 * 
 
0.041 0.010 *** 
Pre-operative score: 29-32 0.149 0.019 *** 
 
0.161 0.010 *** 
 
0.079 0.024 ** 
 
0.067 0.011 *** 
Pre-operative score: 33-36 0.160 0.022 *** 
 
0.168 0.011 *** 
 
0.067 0.028 * 
 
0.079 0.012 *** 
Pre-operative score: 37-40 0.198 0.031 *** 
 
0.203 0.015 *** 
 
0.108 0.039 ** 
 
0.091 0.016 *** 
Pre-operative score: 41-48 0.235 0.057 *** 
 
0.237 0.024 *** 
 
0.067 0.058 
  
0.122 0.028 *** 
Pseudo R2 0.235       0.119       0.195       0.117     
N 60,158       129,945       60,639       142,441     
Notes: *** p<0.001, ** p<0.01, * p<0.05. Estimates are semi-elasticities and relative to pre-operative Oxford score of 0-4. All models include hospital-year fixed effects plus 
a full set of control variables (see text). Standard errors are robust to over-dispersion.
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Figure 1: Distribution of pre-operative Oxford Hip Score 
 
Figure 2: Distribution of pre-operative Oxford Knee Score 
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Figure 3: Partial effect of severity on waiting time 
 
Figure 4: Differential effect of pain and mobility on waiting time 
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Figure 5: Partial effect of severity on waiting time in short and long wait hospitals - hip 
replacement surgery 
 
Figure 6: Partial effect of severity on waiting time in short and long wait hospitals - knee 
replacement surgery 
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8 Appendix 
Appendix 1: Mapping of questions to sub scores - Oxford Hip Score 
# Pain 
1 How would you describe the pain you usually had from your hip? 
2 Have you had any sudden, severe pain - 'shooting', 'stabbing' or 'spasms' - from the 
affected hip? 
3 Have you been troubled by pain from your hip in bed at night? 
4 For how long have you been able to walk before pain from your hip becomes severe? 
(With or without a stick) 
5 After a meal (sat at a table), how painful has it been for you to stand up from a chair 
because of your hip? 
6 How much has pain from your hip interfered with your usual work (including 
housework)? 
   Mobility 
7 Have you had any trouble with washing and drying yourself (all over) because of your 
hip? 
8 Have you had any trouble getting in and out of a car or using public transport because of 
your hip? 
9 Have you been able to put on a pair of socks, stockings or tights? 
10 Could you do the household shopping on your own? 
11 Have you been able to climb a flight of stairs? 
12 Have you been limping when walking, because of your hip? 
 
Appendix 2: Mapping of questions to sub scores - Oxford Knee Score 
# Pain 
1 How would you describe the pain you usually have from your knee? 
2 Have you been troubled by pain from your knee in bed at night? 
3 For how long have you been able to walk before pain from your knee becomes severe? (With 
or without a stick) 
4 After a meal (sat at a table), how painful has it been for you to stand up from a chair because 
of your knee? 
5 How much has pain from your knee interfered with your usual work (including housework)? 
   Mobility 
6 Have you had any trouble with washing and drying yourself (all over) because of your knee? 
7 Have you had any trouble getting in and out of a car or using public transport because of your 
knee? 
8 Have you been limping when walking, because of your knee? 
9 Could you kneel down and get up again afterwards? 
10 Have you felt that your knee might suddenly 'give way' or let you down? 
11 Could you do the household shopping on your own? 
12 Could you walk down one flight of stairs? 
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Appendix 3: Relationship between Oxford Hip Score and the EQ-5D utility score 
 
Appendix 4: Relationship between Oxford Knee Score and the EQ-5D utility score 
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• Patients on waiting list for planned surgery should be prioritised by severity/need 
• The English NHS does not implement a formal prioritisation policy 
• Empirical analysis shows prioritisation by self-reported pain and immobility 
• Pain is more important for prioritisation than mobility 
• Hospitals with longer mean waiting time prioritise more 
